Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
FTLF Stock: Can FitLife Brands Reach the $17.50 Analyst Target After the Recent Drop?

FTLF Stock: Can FitLife Brands Reach the $17.50 Analyst Target After the Recent Drop?

Key Takeaways

  • The central target of $17.50 is the arithmetic mean of the two verified analyst price targets currently available for FTLF.
  • With shares trading near $6.83 after a sharp post-earnings decline, reaching $17.50 would require upside of roughly 156% — a very large move.
  • The analyst target range is narrow but dated: $17 (Roth Capital) to $18 (Lake Street), both carrying Buy ratings.
  • The strongest supporting factors are the Irwin Naturals integration, a planned cost-reduction program, and growing online sales in the MusclePharm and Irwin brands.
  • The biggest risks are declining legacy-brand sales, a fiscal third-quarter earnings miss, elevated leverage, and a weak consumer environment.
  • Investors can find more detail on Major News, Today's Price Move, Forecast, and Earnings on dedicated pages that track this ticker.
  • For additional market insights, readers can also explore Trending AI Robots.

Analyst Price Targets and Consensus View

FitLife Brands, Inc. (FTLF) is a small-cap provider of nutritional supplements and wellness products, best known for brands such as MusclePharm and Irwin Naturals. Only two analysts currently publish price targets on the stock, which limits the statistical weight of any average. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

The two verified targets are $17 from Roth Capital (analyst Sean McGowan, maintained Buy) and $18 from Lake Street Capital Markets (analyst Ryan Meyers, maintained Buy). The arithmetic mean is $17.50, producing a narrow low-to-high range of $17 to $18. Both firms rate the shares a Buy, with no Hold or Sell ratings in the current set.

Importantly, both targets predate the company's November 16, 2026 third-quarter report. Roth Capital had lowered its target from $25 to $17 after the prior quarter, and Lake Street had cut from $21 to $18 in April. Because the stock has since fallen sharply, the existing targets may not yet reflect the latest results and the recently amended credit agreement.

Current Market Position and Path Toward the Target

FitLife shares fell roughly 19% on November 16, closing near $6.83, after the company reported fiscal third-quarter revenue of $25.62 million (up 9% year over year but below estimates) and EPS that missed consensus. Adjusted EBITDA declined 13% to $3.3 million.

Reaching the $17.50 average analyst price target would require a gain of approximately 156% from current levels — a very large move that implies a full recovery to, and beyond, the levels the stock traded at earlier in 2026. Such a path would likely depend on a sustained turnaround in margins and legacy-brand sales rather than a single strong quarter.

What Could Support a Move Toward the Target

Several factors could support a recovery. The acquired Irwin Naturals business generated $13.0 million in revenue during the quarter, up 91% from the prior-year partial period, with online sales and Amazon subscriber counts still growing. MusclePharm posted record online revenue during the quarter. Management also completed a restructuring expected to reduce annual operating expenses by about $1.2 million beginning in the fourth quarter, alongside additional supply-chain cost initiatives aimed at improving online margins.

The stock's low valuation — a single-digit forward P/E and a market capitalization of only about $65 million — means that even a modest operational improvement could translate into a sizable percentage move in the share price, given the small float. From what I see, this valuation setup is worth monitoring closely.

What Could Prevent the Target From Being Reached

The obstacles are substantial. Legacy FitLife revenue fell 24% to $12.6 million, with online sales down 18% and wholesale revenue down 34% on reduced orders from certain retail partners, including GNC. The company cited a weak consumer environment, Amazon algorithm changes, and softness in specialty retail and health-food channels.

Balance-sheet pressure adds risk. The company ended the quarter with $39.3 million in debt against just $0.7 million in cash, and on October 30 it amended its credit agreement to raise the maximum funded-debt-to-EBITDA covenant ratio — a signal of tighter financial flexibility. With the stock near its 52-week low, investor confidence has deteriorated sharply.

Technical Levels and Market Structure

Before the latest drop, the stock's 52-week range was approximately $7.66 to $19.23. The November selloff broke below that prior $7.66 low, with an intraday low near $6.28, meaning the former support level has now become potential resistance. The 52-week high of roughly $19 sits well above even the highest analyst target, underscoring how far the shares have fallen. The $7.50–$8.00 zone may act as an initial hurdle, while round-number levels near $10 and $12 could serve as longer-term reference points on any recovery path.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a roughly 12-month research horizon, though neither firm has published a precise stated timeframe for these targets. Because the targets were issued before the latest earnings report, investors should watch closely for any revisions following the miss.

Key items to monitor include fourth-quarter and full-year results, evidence that the $1.2 million cost-savings program is translating into improved margins, Irwin and MusclePharm online momentum, legacy wholesale and online stabilization, debt reduction and covenant compliance, and any broader shifts in consumer spending on discretionary wellness products. I’m watching this closely for signs of stabilization.

Exploring AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile, thinly traded name like FTLF, these signals can help traders spot shifts in momentum and trend more efficiently than manual scanning alone. In my view, this kind of automated support adds useful context when evaluating names with limited analyst coverage.

Final Assessment

The $17.50 central target is the simple average of two Buy-rated analyst price targets, not a published consensus figure, and it reflects a view formed before the company's latest earnings miss and covenant amendment. At roughly $6.83, the stock would need to climb about 156% to reach that level — a very large move requiring a credible, sustained recovery in margins and legacy-brand sales rather than a single good quarter. The narrow $17-to-$18 analyst range signals broad agreement among the small group of covering firms, but the dated nature of those targets means they carry less weight than they would after a fresh review. The most important near-term signals will be margin improvement from the cost program, stabilization in legacy revenue, debt reduction, and any analyst revisions that follow.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FTLF

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for FTLF turns negative, indicating new downward trend

FTLF saw its Momentum Indicator move below the 0 level on November 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 98 similar instances where the indicator turned negative. In 78 of the 98 cases, the stock moved further down in the following days. The odds of a decline are at 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 35 of 48 cases where FTLF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.

The Moving Average Convergence Divergence Histogram (MACD) for FTLF turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 38 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FTLF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

The Aroon Indicator for FTLF entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for FTLF's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

Following a +3.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where FTLF advanced for three days, in 140 of 211 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

FTLF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.580) is normal, around the industry mean (6.914). P/E Ratio (11.896) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.922) is also within normal values, averaging (5.003).

The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. FTLF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FTLF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Notable companies

The most notable companies in this group are Kraft Heinz Company (The) (NYSE:KHC), General Mills (NYSE:GIS), The Campbell's Company (NASDAQ:CPB), Beyond Meat Inc. (NASDAQ:BYND).

Industry description

Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.

Market Cap

The average market capitalization across the Food: Major Diversified Industry is 3.55B. The market cap for tickers in the group ranges from 68.81K to 239.66B. NSRGY holds the highest valuation in this group at 239.66B. The lowest valued company is THRC at 68.81K.

High and low price notable news

The average weekly price growth across all stocks in the Food: Major Diversified Industry was -4%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -18%. BGS experienced the highest price growth at 36%, while DDC experienced the biggest fall at -38%.

Volume

The average weekly volume growth across all stocks in the Food: Major Diversified Industry was 19%. For the same stocks of the Industry, the average monthly volume growth was 12% and the average quarterly volume growth was -39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 51
Price Growth Rating: 63
SMR Rating: 78
Profit Risk Rating: 92
Seasonality Score: 11 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry FoodMajorDiversified

Industry
N/A
Address
5214 S. 136th Street
Phone
+1 402 991-5618
Employees
81
Web
https://www.fitlifebrands.com
Interact to see
Advertisement
NVIDIA shares declined roughly 26% over the 30 days ending mid-November, falling from a close near $221 to $162.85. The drop left the stock about 30% below its October 6 record intraday high of $243.37 and at a 52-week low.
Micron shares fell -6.28% to $729.40 from Friday's $778.31 close, gapping lower in premarket trading and holding those losses into Monday's regular session. The decline was sector-driven, not company-specific: memory peers SanDisk, SK hynix and Western Digital slid in tandem as last week's Nvidia CEO departure revived doubts over AI data-center spending, financing and memory demand durability.
SKHY fell -6.87% to $122.74 by 10:04 a.m. ET, down $9.05 from Friday's close of $131.79, extending a premarket decline into the regular session. The drop was driven by a sector-wide AI chip selloff ahead of Nvidia's quarterly results on Tuesday, where CEO Jensen Huang's resignation has raised doubts about the durability of data-center spending that underpins high-bandwidth memory demand.
Dell Technologies (DELL) fell roughly 23.7% over the last 30 days, sliding from a closing price of $451.71 on October 16, 2026, to $344.53 on November 13, 2026. The decline accelerated after the U.S. midterm elections, when investor concerns about potential AI and data-center regulation triggered a sharp sell-off across AI hardware names.
ACHR fell -7.44% in Monday's regular session, sliding from Friday's $4.03 close to $3.73 shortly after 10 a.m. ET — a third consecutive daily decline that pushed shares back toward their November 5 low. No verified news or fundamental catalyst found for today's leg lower; the selling extends the de-rating that followed Q3 results — revenue of just $5.1 million, a net loss widening 111% to $274.6 million, and price-target cuts from Cantor Fitzgerald, Needham and Canaccord.